Search Results - Chaohui Zuo

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    RETRACTED: MiRNA‐545 negatively regulates the oncogenic activity of EMS1 in gastric cancer

    RETRACTED: MiRNA‐545 negatively regulates the oncogenic activity of EMS1 in gastric cancer by Min Ma, Juanxia Zhao, Qunfeng Wu, Ke Xiao, Shuang Li, Haizhen Zhu, Chen Liu, Hailong Xie, Chaohui Zuo

    Published 2018-06-01

    Abstract Gastric cancer (GC) is a common malignant tumor of the digestive system. In addition, GC metastasis is an extremely complicated process. In this article, high expression levels of EMS1 mRNA and protein were found to be positively correlated with an enhanced malignant potential of GC cells a...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma

    Interferon-α and thymosin-α1 plus tislelizumab enhance CD8+ T cell cytotoxicity toward pancreatic ductal adenocarcinoma by Shun Deng, Rilin Deng, Jinfeng Wang, Qi Hu, Biaoming Xu, Jinhai Zheng, Mingjing Peng, Wenzhi Tan, Haizhen Zhu, Chaohui Zuo

    Published 2025-08-01

    Summary: The strong immunosuppression and immune evasion of pancreatic ductal adenocarcinoma (PDAC) result in poor efficacy of immune checkpoint blockade. In this study, the PD-1 level on CD8+ T cells in the peripheral blood of patients with PDAC was significantly greater than that in the peripheral...

    Full description

    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells

    MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells by Chaohui Zuo, Xinyi Sheng, Zhuo Liu, Min Ma, Shuhan Xiong, Hongyu Deng, Sha Li, Darong Yang, Xiaohong Wang, Hua Xiao, Hu Quan, Man Xia

    Published 2017-06-01

    Hepatocellular carcinoma is a leading cause of cancer-related mortality worldwide. TRAIL (tumor necrosis factor–related apoptosis–inducing ligand) is a potential target for cancer therapy. However, many cancer cells are resistant to TRAIL-induced apoptosis and its mechanism is not well understood. I...

    Full description

    Get full text
    Article

    Save to List
    Saved in:

Search Tools: